Idiopathic Hypogonadotropic Hypogonadism Clinical Trial
Official title:
Lipid Profile and Oxidative Stress Parameters of Patients With Idiopathic Hypogonadotropic Hypogonadism and the Change of These Parameters With Gonadotropin Replacement Therapy
Verified date | March 2016 |
Source | Gulhane School of Medicine |
Contact | n/a |
Is FDA regulated | No |
Health authority | Turkey: Ethics Committee |
Study type | Observational |
Effects of gonadotrophin replacement therapy Lipid Profile and Oxidative Stress Parameters of Patients with Idiopathic Hypogonadotropic Hypogonadism
Status | Completed |
Enrollment | 30 |
Est. completion date | December 2012 |
Est. primary completion date | December 2012 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 22 Years to 35 Years |
Eligibility |
Inclusion Criteria: Serum testosterone concentration < 300ng/dL Absence of a pituitary or hypothalamic mass lesions, Presence of gonadotropin response to GnRH, - Exclusion Criteria: diabetes mellitus, arterial hypertension other hormone deficiencies |
Observational Model: Case Control, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Gulhane School of Medicine |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | oxidative stress after hCG and HMG treatment | 2010-2012 | No | |
Primary | HDL levels after hCG treatment | 2010-2012 | No | |
Primary | total cholesterole levels after hCG treatment | 2010-2012 | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT01165619 -
Detailed Clinical, Biochemical and Genetic Characterization in Gonadotropin-releasing Hormone (GnRH) Deficiency Disorders
|
N/A | |
Completed |
NCT01914172 -
Health Needs of Patients With Kallmann Syndrome
|
N/A | |
Completed |
NCT02042638 -
The Effects of Gonadotropin Replacement Therapy in Patients With Hypogonadism
|
N/A | |
Active, not recruiting |
NCT02310074 -
Efficacy and Safety of Pulsatile Gonadotropin Releasing Hormone Pump Treatment in Patients With Idiopathic Hypogonadotropic Hypogonadism
|
Phase 4 | |
Completed |
NCT01601327 -
Effects of Medications in Patients With Hypogonadism
|
Phase 4 | |
Completed |
NCT01758094 -
Plasma RBP Levels in Patients With Idiopathic Hypogonadotrophic Hypogonadism
|
N/A | |
Completed |
NCT00493961 -
Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism
|
Phase 1 | |
Recruiting |
NCT05569577 -
An Open Labeled RCT on the Effect of Additional hCG Injection for LPS on Pregnancy Outcomes in IHH Patients
|
N/A |